Literature DB >> 3498933

The human alpha-1-antitrypsin gene is efficiently expressed from two tissue-specific promotors in transgenic mice.

U Rüther1, M Tripodi, R Cortese, E F Wagner.   

Abstract

Alpha 1-antitrypsin (alpha 1AT) present in large amounts in human serum and synthesized predominantly in hepatocytes, is the most abundant protease inhibitor and alpha 1AT mutant proteins are associated with hereditary disorders. To investigate the regulation of the normal human alpha 1AT gene, we have microinjected fertilized mouse eggs with a 17.5 kb DNA fragment containing the entire gene with 7 kb 5' and 0.3 kb 3' flanking sequences. We show that this DNA fragment contains all the information for efficient, accurate and tissue-specific expression. High serum concentration of the human protein was found in three independent transgenic mouse lines. The human alpha 1AT RNA is transcribed efficiently in liver, kidney and macrophages and we demonstrate that two different promoters are used for the expression in liver and macrophages of the transgenic mice.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498933      PMCID: PMC306265          DOI: 10.1093/nar/15.18.7519

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  16 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant.

Authors:  G L Long; T Chandra; S L Woo; E W Davie; K Kurachi
Journal:  Biochemistry       Date:  1984-10-09       Impact factor: 3.162

3.  Two promoters of different strengths control the transcription of the mouse alpha-amylase gene Amy-1a in the parotid gland and the liver.

Authors:  U Schibler; O Hagenbüchle; P K Wellauer; A C Pittet
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

Review 4.  The phenomenon of the acute phase response.

Authors:  I Kushner
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

Review 5.  Structure and variation of human alpha 1-antitrypsin.

Authors:  R W Carrell; J O Jeppsson; C B Laurell; S O Brennan; M C Owen; L Vaughan; D R Boswell
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

6.  The role of macrophages in the induction of antibody in x-irradiated animals.

Authors:  R Gallily; M Feldman
Journal:  Immunology       Date:  1967-02       Impact factor: 7.397

7.  Cell-specific expression of a transfected human alpha 1-antitrypsin gene.

Authors:  G Ciliberto; L Dente; R Cortese
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

8.  An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice.

Authors:  C A Pinkert; D M Ornitz; R L Brinster; R D Palmiter
Journal:  Genes Dev       Date:  1987-05       Impact factor: 11.361

9.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

Authors:  B B Knowles; C C Howe; D P Aden
Journal:  Science       Date:  1980-07-25       Impact factor: 47.728

10.  Specific expression of an elastase-human growth hormone fusion gene in pancreatic acinar cells of transgenic mice.

Authors:  D M Ornitz; R D Palmiter; R E Hammer; R L Brinster; G H Swift; R J MacDonald
Journal:  Nature       Date:  1985 Feb 14-20       Impact factor: 49.962

View more
  17 in total

1.  Chromosomal elements regulate gene activity and chromatin structure of the human serpin gene cluster at 14q32.1.

Authors:  Mark D Marsden; R E K Fournier
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

2.  Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes.

Authors:  L Amicone; F M Spagnoli; G Späth; S Giordano; C Tommasini; S Bernardini; V De Luca; C Della Rocca; M C Weiss; P M Comoglio; M Tripodi
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

3.  Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin-related liver disease in mice.

Authors:  Shuling Guo; Sheri L Booten; Mariam Aghajan; Gene Hung; Chenguang Zhao; Keith Blomenkamp; Danielle Gattis; Andrew Watt; Susan M Freier; Jeffery H Teckman; Michael L McCaleb; Brett P Monia
Journal:  J Clin Invest       Date:  2013-12-20       Impact factor: 14.808

4.  Differential regulation of gene activity and chromatin structure within the human serpin gene cluster at 14q32.1 in macrophage microcell hybrids.

Authors:  P Rollini; R E Fournier
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

5.  Stable expression and cell-specific chromatin structure of human alpha1-antitrypsin cosmid transgenes in rat hepatoma cells.

Authors:  P Rollini; L Xu; R E Fournier
Journal:  Nucleic Acids Res       Date:  2000-09-15       Impact factor: 16.971

6.  Multiple hepatic trans-acting factors are required for in vitro transcription of the human alpha-1-antitrypsin gene.

Authors:  Y Li; R F Shen; S Y Tsai; S L Woo
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

Review 7.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

Review 8.  Transgenic and knockout mice in the study of neurodegenerative diseases.

Authors:  A Aguzzi; S Brandner; S Marino; J P Steinbach
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

Review 9.  Utilization of transgenic mice in the study of matrix degrading proteinases and their inhibitors.

Authors:  R Khokha; D C Martin; J E Fata
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

10.  Extrahepatic expression of plasma protein genes during inflammation.

Authors:  N Kalmovarin; W E Friedrichs; H V O'Brien; L A Linehan; B H Bowman; F Yang
Journal:  Inflammation       Date:  1991-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.